Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPR | P35270 | 1/20 | 0.57 |
| ▸ | ALK | Q9UM73 | 15/20 | 0.56 |
| ▸ | MET | P08581 | 1/20 | 0.53 |
| ▸ | EGFR | P00533 | 3/20 | 0.51 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL571742 | 0.88 | ALK (0.73) | SPRALKMETEGFRIRAK4 | |
| SCHEMBL571730 | 0.85 | SPR (0.51) | SPRALKMETIRAK4 | |
| Hydrochloric Acid SCHEMBL572499 | 0.82 | SPR (0.77) | SPRALKMET | |
| Hydrochloric Acid SCHEMBL572500 | 0.82 | SPR (0.77) | SPRALKMET | |
| SCHEMBL572280 | 0.81 | SPR (0.63) | SPRALKMETEGFRIRAK4 | |
| SCHEMBL572987 | 0.81 | SPR (0.50) | SPRALKMET | |
| SCHEMBL10270132 | 0.80 | ALK (0.85) | SPRALKMETEGFRIRAK4 | |
| SCHEMBL572510 | 0.77 | SPR (0.59) | SPRALKIRAK4 | |
| SCHEMBL572239 | 0.76 | ALK (0.60) | SPRALKMETIRAK4 | |
| SCHEMBL572238 | 0.76 | ALK (0.60) | SPRALKMETIRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2611784-A1 | BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE | Amgen, Inc (US) | 2013-07-10 | — | — | EP | disclosed |
| WO-2012018668-A1 | BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE | AMGEN INC. (US) | 2012-02-09 | — | — | WO | disclosed |